Innovative Live Cell Therapy for Retinitis Pigmentosa in Mexico

Understanding Retinitis Pigmentosa

Retinitis Pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive degeneration of photoreceptor cells in the retina. This degeneration leads to a gradual decline in vision, often beginning with night blindness and peripheral vision loss, eventually progressing to tunnel vision and, in advanced stages, central vision impairment.

Common Symptoms

• Night Blindness: Difficulty seeing in low-light conditions, typically emerging in adolescence.

• Tunnel Vision: Progressive loss of peripheral vision, leading to a narrowed field of view.

• Photopsia: Experiencing flashes or flickering lights.

• Color Vision Deficiency: Altered color perception in advanced stages.

• Associated Conditions: RP may be linked with other health issues, including cataracts, glaucoma, and syndromic conditions like Usher, Bardet-Biedl, and Refsum syndromes.

ProgenCell’s Approach to RP

At ProgenCell, we offer advanced stem cell therapy aimed at slowing the progression of RP and improving visual function. Our treatment protocol involves:​

• Autologous Stem Cell Therapy: Utilizing the patient's own stem cells to promote retinal repair and regeneration.

• Personalized Treatment Plans: Tailored therapies based on individual patient assessments and genetic profiles.

• Comprehensive Care: Integrating supportive therapies to enhance overall ocular health and patient well-being.​

Recent studies have demonstrated the safety and potential efficacy of stem cell therapies in treating RP, offering hope for patients seeking alternatives to traditional treatments.

Why Choose ProgenCell?

• Expertise: A team of experienced specialists in regenerative medicine and ophthalmology.

• State-of-the-Art Facilities: Equipped with cutting-edge technology to ensure the highest standards of care.

• Patient-Centered Care: Focused on individualized treatment plans and continuous support throughout the therapeutic journey.​